# RASGEF1A

## Overview
RASGEF1A is a gene that encodes the protein RasGEF domain family member 1A, which functions as a guanine nucleotide exchange factor (GEF). This protein plays a critical role in cellular signaling by activating Ras-related GTPases through the facilitation of GDP-GTP exchange. As a member of the GEF family, RasGEF domain family member 1A is involved in various signal transduction pathways, particularly those related to oncogenic processes. The gene has been implicated in several diseases, including Hirschsprung's disease and certain cancers, where it may interact synergistically with noncanonical KRAS mutations to enhance Ras pathway activation. This interaction underscores its potential significance in cancer progression and highlights the importance of RASGEF1A in cellular signaling dynamics (Stites2014Cooperation; Fernández2012Four).

## Clinical Significance
Mutations and alterations in the RASGEF1A gene have been implicated in several diseases, notably Hirschsprung's disease (HSCR) and certain cancers. In the context of HSCR, RASGEF1A is located near the RET gene, a known locus associated with the disease. Although common mutations in RASGEF1A have been excluded as a direct cause, the gene may harbor rare mutations that contribute to HSCR susceptibility. Its high expression during early embryonic development suggests a role in enteric neural crest migration, which is crucial for proper intestinal development (Fernández2012Four; Kim2014A).

In cancer, RASGEF1A mutations have been observed to co-occur with noncanonical KRAS mutations, suggesting a synergistic effect that enhances Ras pathway activation. This co-occurrence is particularly significant in the presence of NF1 mutations, where RASGEF1A mutations may increase the sensitivity of the Ras network to perturbations, potentially contributing to cancer progression (Stites2014Cooperation). The imbalance in the expression of Ras GEFs and GAPs, including RASGEF1A, is associated with cellular dysfunction in cancer, indicating its potential role in cancer pathogenesis (Besray2018Systems).

## Interactions
RASGEF1A, a guanine nucleotide exchange factor, is involved in activating Ras-related GTPases by facilitating the exchange of GDP for GTP. It has been identified to interact with various proteins, playing a role in signal transduction pathways. Notably, RASGEF1A has been found to co-occur with noncanonical KRAS mutations in cancer, suggesting a synergistic interaction that enhances Ras pathway activation. This co-occurrence is statistically significant with specific Ras GEFs, including RASGEF1A, indicating that mutations leading to increased GEF activity can potentiate the effects of weakly activating Ras mutations (Stites2014Cooperation).

In the context of cancer, partial activation of Ras GEFs, either through upstream signaling or GEF mutations, can enhance the effects of noncanonical Ras mutations. This interaction is crucial as it suggests that RASGEF1A may play a role in the heightened activation of the Ras pathway, contributing to oncogenic signaling (Stites2014Cooperation).

While specific protein interactions involving RASGEF1A are not detailed in the provided context, its role in facilitating Ras activation and its co-occurrence with KRAS mutations highlight its importance in cellular signaling and potential involvement in cancer progression.


## References


1. (Stites2014Cooperation) Cooperation between Noncanonical Ras Network Mutations in Cancer. This article has 3 citations.

[2. (Fernández2012Four) Raquel Ma Fernández, Marta Bleda, Rocío Núñez-Torres, Ignacio Medina, Berta Luzón-Toro, Luz García-Alonso, Ana Torroglosa, Martina Marbà, Ma Valle Enguix-Riego, David Montaner, Guillermo Antiñolo, Joaquín Dopazo, and Salud Borrego. Four new loci associations discovered by pathway-based and network analyses of the genome-wide variability profile of hirschsprung’s disease. Orphanet Journal of Rare Diseases, December 2012. URL: http://dx.doi.org/10.1186/1750-1172-7-103, doi:10.1186/1750-1172-7-103. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1750-1172-7-103)

[3. (Kim2014A) Jeong-Hyun Kim, Hyun Sub Cheong, Jae Hoon Sul, Jeong-Meen Seo, Dae-Yeon Kim, Jung-Tak Oh, Kwi-Won Park, Hyun-Young Kim, Soo-Min Jung, Kyuwhan Jung, Min Jeng Cho, Joon Seol Bae, and Hyoung Doo Shin. A genome-wide association study identifies potential susceptibility loci for hirschsprung disease. PLoS ONE, 9(10):e110292, October 2014. URL: http://dx.doi.org/10.1371/journal.pone.0110292, doi:10.1371/journal.pone.0110292. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0110292)

[4. (Besray2018Systems) E. Besray Unal, Christina Kiel, Hannah Benisty, Andrew Campbell, Karen Pickering, Nils Blüthgen, Owen J. Sansom, and Luis Serrano. Systems level expression correlation of ras gtpase regulators. Cell Communication and Signaling, August 2018. URL: http://dx.doi.org/10.1186/s12964-018-0256-8, doi:10.1186/s12964-018-0256-8. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-018-0256-8)